News

Fittingly, it was the Canadian prime minister, Mark Carney, who declared the official time of death. The global economy is fundamentally different today than it was yesterday. The system of global ...
What Is Diabetic Macular Edema (DME)? When you have diabetes, you have a lot to manage. High blood sugar can lead to other conditions, like eye problems. One of the most common ones is diabetic ...
Macular edema is swelling in the eye's retina that causes blurry vision but can progress to more serious vision loss. The most common condition associated with macular edema is diabetic retinopathy, ...
We’ve all heard it since childhood — eat your carrots and you’ll see in the dark. Thanks, Bugs Bunny. But while carrots do contain eye-friendly nutrients, they’ve hogged the spotlight for ...
The NSW Government has announced $180,000 in funding to increase access to treatment and support services for people living with macular disease. The one-off grant will support national charity ...
Aims To characterise the association between visual field (VF) defects and myopic macular degeneration (MMD) in highly myopic adults without glaucoma. Methods Participants (n=106; 181 eyes) with high ...
Frontotemporal lobar degeneration (FTLD) is a neurodegenerative disease affecting the frontal and temporal lobes that regulate higher cognitive brain functions such as personality, behavior, and ...
Renal hypoplasia, defined as abnormally small kidneys with normal morphology and reduced nephron number, is a common cause of pediatric renal failure and adult-onset disease. Genetic studies ...
Nephron CEO Lou Kennedy has sold her Lake Murray home for $9.25 million. Provided/Southern Visions Real Estate Lou Kennedy, the president and CEO of one of Lexington County’s largest employers ...
Lou Kennedy, the president and CEO of one of Lexington County’s largest employers, Nephron Pharmaceuticals, has sold her three-acre lake-front home for $9.25 million. The sale broke the record ...
Get Instant Summarized Text (Gist) A new approach targets dual leucine-zipper kinase (DLK) to protect neurons from degeneration without disrupting their normal function. Previous DLK inhibitors ...